BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$24.07 USD
+0.88 (3.80%)
Updated Sep 12, 2024 02:42 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 31% (78 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.71 | 9.99 |
Current Quarter Estimate | -0.09 | 7.56 | 61.00 |
Year Ago Quarter Estimate | -0.67 | 4.52 | 54.84 |
Next Quarter Estimate | -0.07 | 8.55 | 63.00 |
Next Year Estimate | -0.12 | 45.04 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 76.32 | 14.70 | 15.67 |
Next Year | 66.67 | 22.70 | 11.34 |
Last 5 Years | -389.00 | 2.90 | 8.10 |
Next 5 Years | NA | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 2.20 |
Price/Book (MRQ) | 3.32 | 2.20 |
Price/Cash Flow (MRFY) | NA | 11.86 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -59.88% | -9.36% |
Return on Equity (TTM) | -10.75% | -3.53% |
Debt to Equity (MRQ) | 0.04 | 22.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.